All DEPs identified in our study have known roles in process such as the stress response, cell proliferation, apoptosis, energy metabolism, transport, and actin cytoskeleton regulation, suggesting that these processes may also be operative in different phases of anti-Thy1 nephritis (Tables IIIandIV). of S-phase cells and decreasing G2/M-phase cells, whereas inhibiting FHL2 had the opposite effect. This study explored novel DEPs and their expression patterns during anti-Thy1 nephritis, and elucidated FHL2’s effect on mesangial cell proliferation. These results will contribute to our understanding of the pathogenesis of mesangial proliferation. Mesangial proliferative glomerulonephritis (MesPGN)1is the most common chronic kidney disease and is characterized by pathological changes in mesangial cell proliferation and extracellular matrix accumulation. As an important cause of end-stage renal disease, MesPGN has been a major focus of renal disease research. Examining the molecular mechanisms of MesPGN may elucidate its pathogenesis and thereby facilitate the development of clinical treatments. Animal models, such as rat anti-Thy1 nephritis, provide a useful tool to explore these mechanisms. Anti-Thy1 nephritis is a well-established model of mesangial proliferative glomerulonephritis with two major physiological Brassinolide phases (1): the mesangial proliferative phase (e.g.5 and 7 days after anti-Thy1 antibody injection) and the recovery phase (e.g.10 and 14 days after anti-Thy1 antibody injection). Biological functions such as stress (2), cytokine Brassinolide action (3,4), cell proliferation (5,6), and apoptosis (7,8) mediate these Mouse monoclonal to CD8/CD38 (FITC/PE) changes in pathology during the process of anti-Thy1 nephritis. Many proteins have been reported to be involved in regulating these biological functions. For example, Porst (9) reported that fibrillin-1 may regulate mesangial cell proliferation and Brassinolide migration in anti-Thy1 nephritis. Sasakiet al.(6) showed that Galectin-3 modulates rat mesangial cell proliferation and matrix synthesis during experimental glomerulonephritis. However, these studies were limited to a relatively small number of proteins, and it is therefore necessary to examine additional proteins involved in the regulation of the biological functions in anti-Thy1 nephritis. New and powerful tools, such as proteomics, should be used to explore these proteins on a larger scale, as such research could improve current understanding of the molecular processes of anti-Thy1 nephritis. Nazeeret al.(10) used two-dimensional electrophoresis (2DE) techniques to study differences in the proteomic profiles between control and anti-Thy1 nephritis at day 7 and found 16 differentially expressed proteins, providing new insight into the mechanisms of anti-Thy1 nephritis. However, the study examined only day-7 proteins (within the proliferation phase), whereas other time points such as days 10 and Brassinolide 14, which are within the resolution phase, were not analyzed. Here, we examined the different expressed proteins (DEPs) of anti-Thy1 nephritis, including both the proliferative and recovery phases, using 2D fluorescence difference gel electrophoresis (2D-DIGE), which has higher sensitivity and is more reproducible than traditional 2D methods. Brassinolide Among the DEPs, four and a half LIM domain protein 2 (FHL2), whose expression was localized to the mesangial region, was down-regulated on day 3 and 5, and up-regulated on day 10 in anti-Thy1 nephritis, which suggests that the changes in FHL2 expression may be associated with mesangial cell proliferation. It was previously reported that FHL2 has multiple functions associated with cell proliferation. Overexpression of FHL2 inhibits the growth of specific cells, such as colon cancer (11) and hepatoma cells (12), and FHL2 may also promote cell proliferation in mouse fibroblast (13) and glioblastoma cells (14). However, FHL2’s effect on mesangial cell proliferation is not known. In the present study, we explored whether FHL2 induces mesangial cell proliferation.